-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QITDJG6hWg0ptJnYXh1Pec7WEeuZkobMCnnimkviiT1lMEPKxfg1Pru7HBh9kuLG 4DJTvQ4l9M6bt9FBWKvnOw== 0001096906-08-000192.txt : 20080207 0001096906-08-000192.hdr.sgml : 20080207 20080207085500 ACCESSION NUMBER: 0001096906-08-000192 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080207 DATE AS OF CHANGE: 20080207 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Wolf James G. CENTRAL INDEX KEY: 0001419248 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 212-773-3499 MAIL ADDRESS: STREET 1: 35 ORCHARD LANE CITY: RYE STATE: NY ZIP: 10580 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HEMACARE CORP /CA/ CENTRAL INDEX KEY: 0000801748 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 953280412 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-38283 FILM NUMBER: 08583205 BUSINESS ADDRESS: STREET 1: 15350 SHERMAN WAY STREET 2: SUITE 350 CITY: VAN NUYS STATE: CA ZIP: 91406 BUSINESS PHONE: 818-226-1968 MAIL ADDRESS: STREET 1: 15350 SHERMAN WAY STREET 2: SUITE 350 CITY: VAN NUYS STATE: CA ZIP: 91406 SC 13G/A 1 jameswolfsc13ga1.htm jameswolfsc13ga1.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A
(Amendment No. 1)
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED PURSUANT TO RULE 13d-2

HEMACARE CORPORATION

(Name of Issuer)

COMMON STOCK, NO PAR VALUE
(Title of Class of Securities)

423498104
(CUSIP Number)

November 8, 2007
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 
a.
o  Rule 13d-1(b)
 
b.
x  Rule 13d-1(c)
 
c.
o  Rule 13d-1(d)













* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).





CUSIP No. 4234498104
Page 2 of 4
 

1.
Name of Reporting Person

James G. Wolf


2.
Check The Appropriate Box if a Member of a Group

(a)   [ ]
(b)   [ ]

3.
SEC Use Only



4.
Citizenship or Place of Organization

U.S.A.

 
Number of Shares
5.   Sole Voting Power
Beneficially
 
Owned By Each
800,000
Reporting Person
 
With
6.   Shared Voting Power
   
 
None
   
 
7.   Sole Dispositive Power
   
 
800,000
   
 
8.   Shared Dispositive Power
   
 
None

9.
Aggregate Amount Beneficially Owned By Each Reporting Person

800,000


10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

[ ]


11.
Percent of Class Represented By Amount in Row (9)

9.1%


12.
Type of Reporting Person

IN

 






CUSIP No. 423498104
Page 3 of 4



ITEM
1(a)
Name of Issuer:

Hemacare Corporation

 
1(b)
Address of Issuer’s Principal Executive Offices:

15350 Sherman Way, Suite 350
Van Nuys, California 91406

ITEM
2(a)
Name of Person Filing:

James G. Wolf

 
2(b)
Address of Principal Office or, if none, Residence:

35 Orchard Lane
Rye, NY 10580

 
2(c)
Citizenship:

U.S.A.

 
2(d)
Title of Class of Securities:

Common Stock, no par value

 
2(e)
CUSIP Number:

423498104

ITEM  3
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
 
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
 
(e)
An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E);
 
(f)
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
(g)
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
 
(h)
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
(j)
Group, in accordance with §240.13d-1(b)(1)(ii)(J).





CUSIP No. 423498104
Page 4 of 4


ITEM 4.
OWNERSHIP.

The responses to Items 5 through 11 on the cover page of this filing are incorporated by reference.

ITEM 5.
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

Not Applicable.

ITEM 6.
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not Applicable.

ITEM 7.
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not Applicable.

ITEM 8.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not Applicable.

ITEM 9.
NOTICE OF DISSOLUTION OF GROUP.

Not Applicable.

ITEM 10.
CERTIFICATION

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participation in any transaction having that purpose or effect.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:  February 6, 2008
/s/ James G. Wolf
 
James G. Wolf




-----END PRIVACY-ENHANCED MESSAGE-----